Introduction
============

To study the clinical and paraclinical response to therapy in patients with ventilator-associated pneumonia (VAP).

Methods
=======

A prospective, 4-year study of 450 patients ventilated over 48 hours. Patients were compared according to four age groups: Group I (\<35 years), Group II (35--55 years), Group III (55--79 years) and Group IV (\>80 years). Patients and VAP characteristics, ICU and hospital lengths of stay (LOSs), duration of mechanical ventilation (MV)--intubation (TT), patient outcome and the first day of normalization of each clinical and paraclinical parameter were studied using Pearson\'s chi-square test and one-way ANOVA.

Results
=======

One hundred and thirty-four patients developed VAP. Twenty-five (18.6%) patients of Group I had (mean ± SD) APACHE II score 16.5 ± 3.6, MV 19.08 ± 7.8, TT 21.7 ± 8.4, ICU LOS 25.04 ± 11.5 days, hospital LOS 18.4 ± 10.3 days, ICU mortality 3 (12%), hospital mortality 0 (0%). Thirty-eight (28.4%) patients of Group II had APACHE II score 18.5 ± 5.7, MV 24.08 ± 10.8, TT 29.7 ± 10.6, ICU LOS 33.04 ± 12.5 days, hospital LOS 28.4 ± 11.3 days, ICU mortality 5 (20.8%), hospital mortality 6 (21.4%). Sixty (44.8%) patients of Group III had APACHE II score 21.4 ± 5.6, MV 31.1 ± 16.5, TT 32.8 ± 16.8, ICU LOS 37.04 ± 13.8 days, hospital LOS 34.2 ± 14.1 days, ICU mortality 15 (25%), hospital mortality 16 (26.6%). Ten (7.5%) patients of Group IV had APACHE II score 26.3 ± 4.5, MV 41.6 ± 10.5, TT 45.8 ± 14.7, ICU LOS 49.04 ± 15.2 days, hospital LOS 47.6 ± 18.7 days, ICU mortality 3 (30%), hospital mortality 5 (50%). The APACHE II score (*P*\< 0.001), duration of MV (*P*\< 0.02) and TT (*P*\< 0.04), hospital mortality (*P*\< 0.001), hospital LOS (*P*\< 0.01), and MODS (*P*\< 0.04) differ statistically significantly. ICU mortality (*P*\< 0.4), CPIS (*P*\< 0.7), and duration of antibiotic treatment (*P*\< 0.6) did not differ significantly. VAP was caused by MDR Gram(-) microorganisms, except for three cases caused by MRSA (*P*\< 0.8). Time resolution for temperature was 7 days (6.6. ± 1.1, *P*\< 0.1), leucocyte 6 days (5.8 ± 1.2, *P*\< 0.5), hemodynamic stability 5 days (4.8 ± 0.8, *P*\< 0.3), normalization of PaO~2~/FiO~2~4 days (3.9 ± 0.7, *P*\< 0.07), and microbiological eradication 10 days (9.3 ± 1.1, *P*\< 0.3). Colonization after VAP resolution was higher in the elderly patients (*P*\< 0.02).

Conclusion
==========

Age does not influence the clinical response to therapy. Patients in whom the tracheobronchial aspirates were not sterilized after the resolution of VAP are at higher risk of a longer time of hospitalization and of dying after discharge from the ICU.
